Biphenotypic Blast Crisis of Chronic Myelogenous Leukemia: Abnormalities of p53 and Retinoblastoma Genes

References

• Daley G. Q., Van Etten R. A., Baltimore D. Induction of chronic myelogenous leukemia in mice by the p210bcr/abl gene of the Philadelphia chromosome. Science 1990; 247: 824–829
   PubMed Web of Science ®Google Scholar
• Cannistra S. A. Chronic myelogenous leukemia as a model for the genetic basis of cancer. Hematol. Oncol. Clin. North. Am. 1990; 4: 337–357
   PubMed Web of Science ®Google Scholar
• Kantarjian H. M., Deisseroth A., Kurzrock R., Estrov Z., Talpaz M. Chronic myelogenous leukemia: A concise update. Blood 1993; 82: 691–703
   PubMed Web of Science ®Google Scholar
• Thomas E. D., Clift R. A., Fefer A., Appelbaum F. R., Beatty P., Bensinger W. I., Buckner C. D., Cheever M. A., Deeg H. J., Doney K., Flournoy N., Greenberg P., Hansen J. A., Martin P., McGuffin R., Ramberg R., Sanders J. E., Singer J., Stewart P., Storb R., Sullivan K., Weiden P. L., Witherspoon R. Marrow transplantation for the treatment of chronic myelogenous leukemia. Ann. Inter. Med. 1986; 104: 155–163
   PubMed Web of Science ®Google Scholar
• Liu E., Hjelle B., Bishop J. M. Transforming genes in chronic myelogenous leukemia. Pro. Natl. Acad. Sci. USA 1988; 85: 1952–1956
   PubMed Web of Science ®Google Scholar
• McCarthy D. M., Rassool F. V., Goldman J. M., Graham S. V., Birnie G. D. Genomic alterations involving the c‐myc proto‐oncogene locus during the evolution of a case of chronic granulocytic leukemia. Lancet 1984; ii: 1362–1365
   Google Scholar
• Ahuja H. G., Jat P. S., Foti A., Bar‐Eli M., Cline M. S. Abnormalities of the retinoblastoma gene in pathogen‐esis of acute leukemia. Blood 1991; 78: 3259–3268
   PubMed Web of Science ®Google Scholar
• Ahuja H., Bar‐Eli M., Advani S. H., Benchimol S., Cline M. J. Alterations of p53 gene and the clonal evolution of the blast crisis of chronic myelocytic leukemia. Proc. Natl. Acad. Sci. USA 1989; 86: 6783–6787
   PubMed Web of Science ®Google Scholar
• Mulligan M. L., Matlashewski G. J., Scrable H. J., Cavanee W. K. Mechanisms of p53 loss in human sarcomas. Proc. Natl. Acad. Sci. USA 1990; 87: 5863–5867
   PubMed Web of Science ®Google Scholar
• Yandell D. W., Se D., Campbell T. A. Oncogenic point mutation in the human retinoblastoma gene: their application to genetic counseling. N. Engl. J. Med. 1989; 321: 1689–1695
   PubMed Web of Science ®Google Scholar
• Kelman Z., Prokocimer M., Peller S., Kahn Y., Rechavi G., Manor Y., Cohen A., Rotter V. Rearrangements of p53 gene in Philadelphia positive chronic myelocytic leukemia. Blood 1989; 74: 2318–2324
   PubMed Web of Science ®Google Scholar
• Marshal R., Shtalrid M., Talpaz M., Kantarjian H., Smith L., Beran M., Cork A., Turjillo J., Gutterman J., Deisseroth A. Rearrangement and expression of p53 gene in the chronic phase and blast crisis of chronic myelogenous leukemia. Blood 1990; 75: 180–189
   PubMed Web of Science ®Google Scholar
• Cline M. J., Jat P. S., Foti A. Molecular mechanisms in the evolution of chronic myelocytic leukemia. Leuk. Lymph. 1992; 7: 283–287
   PubMed Web of Science ®Google Scholar
• Maniatis T., Fritsch E. F., Sambrook J. J. Molecular cloning: A Laboratory Manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY 1982
   Google Scholar
• Wiggs J., Nordenskjold M., Yandell D., Rapaport J., Grondin V., Janson M., Werelius B., Petersen R., Craft A., Riedel K., Liberfarb R., Walton D., Wilson W., Dryja T. P. Prediction of the risk of hereditary retinoblastoma, using DNA polymorphisms within the retinoblastoma gene. N. Engl. J. Med. 1988; 318: 151–157
   PubMed Web of Science ®Google Scholar
• Ahuja H., Bar‐Eli M., Clarke P., Snyder D., Foreman S., Goldman J., Cline M. J. p53 gene alterations in blast crisis of chronic myelogenous leukemia. Cancer Cells 1989; 7: 117–120
   Google Scholar
• Gale R. P., Ben‐Bassat I. Annotation: Hybrid acute leukaemia, fin. J. Haematol. 1987; 65: 261–264
   Web of Science ®Google Scholar
• Alimena G., Dallapiccola B., Gastaloi R., Mandelli F., Brandt L., Mitelman F., Nilsson P. G. Chromosomal, morphological and clinical correlations in blastic crisis of chronic myeloid leukaemia. A study of 69 cases. Scand. J. Haematol. 1982; 28: 103–117
   PubMedGoogle Scholar
• Griffin J. D., Todd R. F., III, Ritz J., Nadler L. M., Canellos G. P., Rosenthal D., Gallivan M., Beveridge R. P., Weinstein H., Karp D., Schlossman S. F. Differentiation patterns in the blastic phase of chronic myeloid leukemia. Blood 1983; 61: 85–91
   PubMed Web of Science ®Google Scholar
• Okawa H. Immunologic classification of leukemia. Pediatric review 1988; 21: 41–65
   Google Scholar
• Rowley J. D., Testa J. R. Chromosome abnormalities in malignnt hematologic diseases. Adv. Cancer Res. 1982; 36: 103–148
   PubMed Web of Science ®Google Scholar
• Miller C., Mohandas T., Wolf D., Prokocimer M., Rotter V., Koeffler H. P. Human p53 gene localized to short arm of chromosome 17. Nature 1986; 319: 783–784
   PubMed Web of Science ®Google Scholar
• Feinstein E., Cimino G., Gale R. P., Alimena G., Berthier R., Kishi K., Goldman J., Zaccaria A., Berrabi A., Canaani E. p53 in chronic myelogenous leukemia in acute phase. Pro. Natl. Acad. Sci. USA 1991; 85: 1952–1956
   Google Scholar
• Nakai H., Misawa S., Taniwaki M., Horiike S., Takashima T., Seriu T., Nakagawa H., Fujii H., Shimazaki C., Maruo N., Akaogi T., Uike N., Abe T., Kashima K. Prognostic significance of loss of a chromosome 17p and p53 gene mutation in blast crisis of chronic myelogenous leukemia. Br. J. Haematol. 1994; 87: 425–427
   PubMed Web of Science ®Google Scholar
• Weinberg R. A. Tumor suppressor genes. Science 1991; 254: 1138–1146
   PubMed Web of Science ®Google Scholar
• Furukawa Y., DeCaprio J. A., Belvin M., Griffin J. D. Heterogenous expression of the product of the retinoblastoma susceptibility gene in primary human leukemia cells. Oncogene 1991; 6: 1343–1346
   PubMed Web of Science ®Google Scholar
• Furukawa Y. Tumor suppressor genes and their role in abnormal production of leukocytes (Leukemogenesis). Jpn. J. Clin. Hematol 1993; 34: 572–577
   PubMedGoogle Scholar
• Tang J. ‐L., Yeh S. ‐H., Chen P. ‐J., Lin M. ‐T., Tien H. ‐F., Chen Y. ‐C. Inactivation of the retinoblastoma gene in acute myelogenous leukaemia. Br. J. Haematol. 1992; 82: 502–507
   PubMed Web of Science ®Google Scholar
• Kornblau S. M., Xu H. ‐J., Zhang W., Hu S. ‐W., Beran M., Smith T. L., Hester J., Estey E., Benedict W. F., Deisserroth A. B. Levels of retinoblastoma protein expression in newly diagnosed acute myelogenous leukemia. Blood 1994; 84: 256–261
   PubMed Web of Science ®Google Scholar
• Cline M. J. Mechanisms of disease: The molecular basis of leukemia. N. Eng. J. Med 1994; 330: 328–336
   PubMed Web of Science ®Google Scholar
• Towatari M., Adachi K., Kato H., Saito H. Absence of the human retinoblastoma gene product in the megakaryoblastic crisis of chronic myelogenous leukemia. Stood 1991; 78: 2178–2181
   Google Scholar
• Sill H., Goldman J. M., Cross N. C. P. Homozygous deletions of the p16 tumor‐suppressor gene are associated with lymphoid transformation of chronic myeloid leukemia. Blood 1995; 85: 2013–2016
   PubMed Web of Science ®Google Scholar